BeStock  
Stocks › Biotechnology › GERN

Geron GERN

US equityMarket cap rank #3527Biotechnology
$0.87 −$0.04 (-4.63%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $0.89 +2.45%
Open$0.89
Prev close$0.91
Day range$0.86 – $0.93
Volume13.83M
Market cap$560.94M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$60.19M+27.4% YoY
Operating profit$5.73M+141.2% YoY
Net profit$1.35M+107.3% YoY
Diluted EPS$0.00+100.0% YoY
Free cash flow$10.11M+175.0% YoY
Operating cash flow$10.27M

Revenue, last 8 quarters

$47.5MDec '24$39.6MMar '25$49.0MJun '25$47.2MSep '25$48.0MDec '25$51.8MMar '26$57.5MJun '26$60.2MSep '26

Net profit, last 8 quarters

$-25.4MDec '24$-19.8MMar '25$-16.4MJun '25$-18.4MSep '25$-28.9MDec '25$-3.6MMar '26$-16.7MJun '26$1.4MSep '26

Diluted EPS by quarter

-0.04Dec '24-0.03Mar '25-0.02Jun '25-0.03Sep '25-0.05Dec '25-0.01Mar '26-0.02Jun '260.00Sep '26

Free cash flow by quarter

$-43.8MDec '24$-48.0MMar '25$-27.6MJun '25$-13.5MSep '25$-22.1MDec '25$-63.2MMar '26$-16.1MJun '26$10.1MSep '26

Annual revenue

$253.0KFY20$1.4MFY21$596.0KFY22$237.0KFY23$77.0MFY24$183.9MFY25

Profitability & balance sheet

Gross margin91.6%
Operating margin-7.2%
Net margin-22.0%
Return on equity-20.1%
Return on assets-8.7%
Return on invested capital-9.0%
Current ratio6.31
Liabilities / assets57.0%
Cash & investments$286.48M
Total debt$120.44M
Net cash (debt)$166.04M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $60.19M $57.48M $51.84M – –
Total Operating Revenue $60.19M $57.48M $51.84M $183.88M $48.02M
Cost of Revenue $6.05M $9.24M $1.69M $4.75M $1.31M
Gross Profit $54.14M $48.24M $50.15M $179.14M $46.71M
Operating Expense $48.41M $60.89M $50.38M $230.69M $55.22M
Selling and Admin Expenses $35.70M $38.86M $35.43M $159.26M $41.67M
Research & Development $12.71M $22.03M $14.96M $71.43M $13.55M
Operating Profit $5.73M -$12.65M -$236,000.00 -$51.55M -$8.51M
Net Non-Operating Interest Income (Expense) -$4.18M -$4.18M -$3.73M -$14.54M -$3.25M
Non-Operating Interest Income $3.03M $2.97M $3.42M $18.12M $4.05M
Non-Operating Interest Expense $7.21M $7.15M $7.15M $32.66M $7.30M
Other Income (Expense) -$196,000.00 $148,000.00 $320,000.00 -$17.41M -$17.10M
Special Income (Charges) $71,000.00 $157,000.00 $394,000.00 -$17.03M -$17.03M
-Less:Restructuring and Mergern & Acquisition -$71,000.00 -$157,000.00 -$394,000.00 $17.03M $17.03M
Other Non-Operating Income (Expenses) -$267,000.00 -$9,000.00 -$74,000.00 -$375,000.00 -$70,000.00
Pretax Profit $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Net Profit $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Profit from Continuing Operations $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Net Income to Parent Company $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Net Income to Common Stockholders $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Basic EPS $0.00 -$0.02 -$0.01 -$0.13 -$0.05
Diluted EPS $0.00 -$0.02 -$0.01 -$0.13 -$0.05

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $527.11M $519.01M $534.12M $570.54M $570.54M
Total Current Assets $468.74M $486.34M $498.53M $520.27M $520.27M
Cash and Cash Equivalents & Short-Term Investments $286.48M $300.85M $312.40M $357.92M $357.92M
-Cash and Cash Equivalents $69.18M $62.64M $68.90M $77.56M $77.56M
-Short Term Investments $217.30M $238.21M $243.51M $280.36M $280.36M
Receivables $48.01M $53.50M $44.10M $39.23M $39.23M
-Accounts Receivable $45.98M $51.64M $41.88M $36.99M $36.99M
-Accrued Interest Receivable $2.03M $1.86M $2.21M $2.24M $2.24M
Inventory $126.60M $123.60M $133.29M $116.64M $116.64M
Restricted Cash $1.89M $1.89M $1.88M $1.88M $1.88M
Other Current Assets $5.76M $6.50M $6.86M $4.61M $4.61M
Total Non-Current Assets $58.36M $32.67M $35.59M $50.27M $50.27M
Net PPE $1.67M $2.85M $2.96M $3.04M $3.04M
-Gross PPE $1.67M $2.85M $2.96M $5.24M $5.24M
Investments and Advances $51.00M $24.12M $26.69M $41.29M $41.29M
-Available for Sale Securities $51.00M $24.12M $26.69M – –
Other Non-Current Assets $5.70M $5.70M $5.94M $5.95M $5.95M
Total Liabilities $300.41M $300.40M $305.01M $344.67M $344.67M
Total Current Liabilities $74.25M $70.33M $73.57M $111.54M $111.54M
Payables $15.46M $8.81M $12.72M $11.26M $11.26M
-Accounts Payable $15.46M $8.81M $12.72M $11.26M $11.26M
Current Accrued Expenses $17.97M $24.01M $25.40M $47.85M $47.85M
Short-Term Debt and Capital Lease Obligation $789,000.00 $1.01M $1.01M $1.00M $1.00M
-Current Capital Lease Obligation $789,000.00 $1.01M $1.01M $1.00M $1.00M
Current Deferred Liabilities $5.94M $6.70M $5.56M $3.49M $3.49M
Other Current Liabilities $23.32M $20.69M $19.39M $17.45M $17.45M
Total Non-Current Liabilities $226.16M $230.06M $231.44M $233.13M $233.13M
Long Term Debt and Capital Lease Obligation $120.44M $121.13M $121.06M $120.99M $120.99M
-Long Term Debt $120.44M $120.13M $119.83M $119.55M $119.55M
-Long Term Capital Lease Obligation $0.00 $1.00M $1.23M $1.45M $1.45M
Other Non-Current Liabilities $105.72M $108.93M $110.38M $112.13M $112.13M
Total Equity $226.70M $218.61M $229.11M $225.87M $225.87M
Stockholders' Equity $226.70M $218.61M $229.11M $225.87M $225.87M
Capital Stock $644,000.00 $642,000.00 $641,000.00 $640,000.00 $640,000.00
-Common Stock $644,000.00 $642,000.00 $641,000.00 $640,000.00 $640,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.10B $2.09B $2.09B $2.08B $2.08B
Retained Earnings -$1.87B -$1.88B -$1.86B -$1.86B -$1.86B
Gains/Losses Not Affecting Retained Earnings -$587,000.00 -$339,000.00 -$191,000.00 $269,000.00 $269,000.00
-Accumulated Depreciation – – – -$2.20M -$2.20M
-Held to Maturity Securities – – – $41.29M $41.29M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $10.27M -$15.83M -$62.91M -$111.04M -$22.07M
Net cash flow from continuing operations $10.27M -$15.83M -$62.91M -$111.04M -$22.07M
Net Income from Continuing Operations $1.35M -$16.68M -$3.64M -$83.50M -$28.86M
Depreciation & Depletion & Amortization $336,000.00 $332,000.00 $326,000.00 $1.20M $275,000.00
Other Non-Cash Items -$275,000.00 $150,000.00 $477,000.00 $20.02M $14.69M
Change in Working Capital -$345,000.00 -$9.38M -$63.91M -$68.54M -$12.47M
-Change in Receivables $5.66M -$8.94M -$4.89M -$377,000.00 -$966,000.00
-Change in Inventory -$7.87M $3.35M -$16.65M -$77.92M -$21.21M
-Change in Prepaid Assets $569,000.00 $974,000.00 -$2.23M -$1.42M -$1.59M
-Change in Payables and Accrued Expense -$19.88M -$4.17M -$18.91M $18.45M $17.98M
-Change in Other Current Liabilities -$223,000.00 -$220,000.00 -$212,000.00 -$14.96M -$14.37M
Net cash flow from investing -$5.91M $8.30M $51.86M $107.25M $21.15M
Net Cash Flow from Continuing Investing Activities -$5.91M $8.30M $51.86M $107.25M $21.15M
Net PPE Purchase and Sale -$154,000.00 -$223,000.00 -$252,000.00 -$49,000.00 $0.00
Net Investment Purchase and Sale -$5.76M $8.52M $52.11M $107.30M $21.15M
Financing Cash Flow $2.17M $1.38M $2.43M $2.27M $378,000.00
Net Cash Flow from Continuing Financing Activities $2.17M $1.38M $2.43M $2.27M $378,000.00
Proceeds from Stock Option Exercised $2.17M $1.38M $2.43M $2.27M $378,000.00
Ending Cash Balance $71.07M $64.53M $70.78M $79.44M $79.44M
Net Change in Cash $6.52M -$6.15M -$8.63M -$1.52M -$544,000.00
Beginning Cash Balance $64.53M $70.78M $79.44M $80.88M $79.99M
Effect of Exchange Rate Changes $16,000.00 -$100,000.00 -$36,000.00 $87,000.00 -$9,000.00
Free Cash Flow $10.11M -$16.05M -$63.16M -$111.09M -$22.07M
-Change In Other Working Capital – -$382,000.00 -$21.01M $7.69M –
Net Issuance Payments Of Debt – – – $0.00 –
Net Common Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on GERN.

Sign in to join the discussion.

Scroll to Top